Human Interleukin-2 (IL-2) Market Report

China Human Interleukin-2 (IL-2) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 05, 2023
  • PAGES：189
  • REPORT CODE：GMM1777892
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Human Interleukin-2 (IL-2) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Guangdong Xinghao Pharmaceutical

    • Xiamen Tebao Biological Engineering

    • Beijing Sihuan Biological Pharmaceutical

    • Philogen

    • Shenyang Sansheng Pharmaceutical

    • Schering-Plough

    • APT Therapeutics

    • Alkermes Plc

    • Beijing Shuanglu Pharmaceutical

    • AbbVie Inc

    • Jiangsu Jinsili Pharmaceutical

    • Shenzhen Kexing Biological Engineering

    • Sinopharm

    • Roche

    • Beijing Sanyuan Gene Pharmaceutical

    • Shanghai Pharma Group

    • Shandong Quangang Pharmaceutical

    • Shanghai Sanwei Biotechnology

    • Chengdu huashen Biotechnology

    • Mabtech Limited

    By Type:

    • 50000 U

    • 100000 U

    • 2 Million U

    • 500000 U

    • 200000 U

    • 1 Million U

    By Application:

    • Recombinant Interferon

    • Gene Therapy

    • Recombinant Interleukin

    • Natural Biological Products

    • Monoclonal Antibody

    • Poison Immune

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Human Interleukin-2 (IL-2) Market Overview 2018-2029

    • 1.1 China Human Interleukin-2 (IL-2) Industry Development Overview

    • 1.2 China Human Interleukin-2 (IL-2) Industry Development History

    • 1.3 China Human Interleukin-2 (IL-2) Industry Market Size (2018-2029)

    • 1.4 China Human Interleukin-2 (IL-2) Market Analysis by Type from Production Side

      • 1.4.1 China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 50000 U (2018-2029)

      • 1.4.2 China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 100000 U (2018-2029)

      • 1.4.3 China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 2 Million U (2018-2029)

      • 1.4.4 China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 500000 U (2018-2029)

      • 1.4.5 China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 200000 U (2018-2029)

      • 1.4.6 China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 1 Million U (2018-2029)

    • 1.5 China Human Interleukin-2 (IL-2) Market Analysis by Application from Consumption End

      • 1.5.1 China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Recombinant Interferon (2018-2029)

      • 1.5.2 China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Gene Therapy (2018-2029)

      • 1.5.3 China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Recombinant Interleukin (2018-2029)

      • 1.5.4 China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Natural Biological Products (2018-2029)

      • 1.5.5 China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Monoclonal Antibody (2018-2029)

      • 1.5.6 China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Poison Immune (2018-2029)

    • 1.6 China Human Interleukin-2 (IL-2) Market Analysis by Region

      • 1.6.1 North China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Human Interleukin-2 (IL-2) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Human Interleukin-2 (IL-2) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Human Interleukin-2 (IL-2) Market Status and Competition Analysis in 2023

      • 2.2.3 China Human Interleukin-2 (IL-2) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Human Interleukin-2 (IL-2) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Human Interleukin-2 (IL-2) Industry Development

    Chapter 3 Human Interleukin-2 (IL-2)Industry Chain Analysis

    • 3.1 Human Interleukin-2 (IL-2) Industry Chain

    • 3.2 Human Interleukin-2 (IL-2) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Human Interleukin-2 (IL-2) Market

    • 3.3 Human Interleukin-2 (IL-2) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Human Interleukin-2 (IL-2) Market

    Chapter 4 China Human Interleukin-2 (IL-2) Market, by Type

    • 4.1 China Human Interleukin-2 (IL-2) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Human Interleukin-2 (IL-2) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Human Interleukin-2 (IL-2) Production Volume and Growth Rate, by Type

      • 4.5.1 China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 50000 U

      • 4.5.2 China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 100000 U

      • 4.5.3 China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 2 Million U

      • 4.5.4 China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 500000 U

      • 4.5.5 China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 200000 U

      • 4.5.6 China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 1 Million U

    Chapter 5 China Human Interleukin-2 (IL-2) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Human Interleukin-2 (IL-2) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Human Interleukin-2 (IL-2) Market Size and Growth Rate, by Application

      • 5.5.1 China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Recombinant Interferon

      • 5.5.2 China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Gene Therapy

      • 5.5.3 China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Recombinant Interleukin

      • 5.5.4 China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Natural Biological Products

      • 5.5.5 China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Monoclonal Antibody

      • 5.5.6 China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Poison Immune

    Chapter 6 China Human Interleukin-2 (IL-2) Market, by Region

    • 6.1 China Human Interleukin-2 (IL-2) Production Volume and Production Value, by Region

    • 6.2 China Human Interleukin-2 (IL-2) Sales Volume and Sales Value, by Region

    Chapter 7 North China Human Interleukin-2 (IL-2) Market Analysis

    • 7.1 North China Human Interleukin-2 (IL-2) Market, by Type

    • 7.2 North China Human Interleukin-2 (IL-2) Market, by Application

    Chapter 8 Central China Human Interleukin-2 (IL-2) Market Analysis

    • 8.1 Central China Human Interleukin-2 (IL-2) Market, by Type

    • 8.2 Central China Human Interleukin-2 (IL-2) Market, by Application

    Chapter 9 South China Human Interleukin-2 (IL-2) Market Analysis

    • 9.1 South China Human Interleukin-2 (IL-2) Market, by Type

    • 9.2 South China Human Interleukin-2 (IL-2) Market, by Application

    Chapter 10 East China Human Interleukin-2 (IL-2) Market Analysis

    • 10.1 East China Human Interleukin-2 (IL-2) Market, by Type

    • 10.2 East China Human Interleukin-2 (IL-2) Market, by Application

    Chapter 11 Northeast China Human Interleukin-2 (IL-2) Market Analysis

    • 11.1 Northeast China Human Interleukin-2 (IL-2) Market, by Type

    • 11.2 Northeast China Human Interleukin-2 (IL-2) Market, by Application

    Chapter 12 Southwest China Human Interleukin-2 (IL-2) Market Analysis

    • 12.1 Southwest China Human Interleukin-2 (IL-2) Market, by Type

    • 12.2 Southwest China Human Interleukin-2 (IL-2) Market, by Application

    Chapter 13 Northwest China Human Interleukin-2 (IL-2) Market Analysis

    • 13.1 Northwest China Human Interleukin-2 (IL-2) Market, by Type

    • 13.2 Northwest China Human Interleukin-2 (IL-2) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Guangdong Xinghao Pharmaceutical

        • 14.1.1 Guangdong Xinghao Pharmaceutical Company Profile

        • 14.1.2 Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Xiamen Tebao Biological Engineering

        • 14.2.1 Xiamen Tebao Biological Engineering Company Profile

        • 14.2.2 Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Beijing Sihuan Biological Pharmaceutical

        • 14.3.1 Beijing Sihuan Biological Pharmaceutical Company Profile

        • 14.3.2 Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Philogen

        • 14.4.1 Philogen Company Profile

        • 14.4.2 Philogen Human Interleukin-2 (IL-2) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Shenyang Sansheng Pharmaceutical

        • 14.5.1 Shenyang Sansheng Pharmaceutical Company Profile

        • 14.5.2 Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Schering-Plough

        • 14.6.1 Schering-Plough Company Profile

        • 14.6.2 Schering-Plough Human Interleukin-2 (IL-2) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 APT Therapeutics

        • 14.7.1 APT Therapeutics Company Profile

        • 14.7.2 APT Therapeutics Human Interleukin-2 (IL-2) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Alkermes Plc

        • 14.8.1 Alkermes Plc Company Profile

        • 14.8.2 Alkermes Plc Human Interleukin-2 (IL-2) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Beijing Shuanglu Pharmaceutical

        • 14.9.1 Beijing Shuanglu Pharmaceutical Company Profile

        • 14.9.2 Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 AbbVie Inc

        • 14.10.1 AbbVie Inc Company Profile

        • 14.10.2 AbbVie Inc Human Interleukin-2 (IL-2) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Jiangsu Jinsili Pharmaceutical

        • 14.11.1 Jiangsu Jinsili Pharmaceutical Company Profile

        • 14.11.2 Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Shenzhen Kexing Biological Engineering

        • 14.12.1 Shenzhen Kexing Biological Engineering Company Profile

        • 14.12.2 Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Sinopharm

        • 14.13.1 Sinopharm Company Profile

        • 14.13.2 Sinopharm Human Interleukin-2 (IL-2) Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Roche

        • 14.14.1 Roche Company Profile

        • 14.14.2 Roche Human Interleukin-2 (IL-2) Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Beijing Sanyuan Gene Pharmaceutical

        • 14.15.1 Beijing Sanyuan Gene Pharmaceutical Company Profile

        • 14.15.2 Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Shanghai Pharma Group

        • 14.16.1 Shanghai Pharma Group Company Profile

        • 14.16.2 Shanghai Pharma Group Human Interleukin-2 (IL-2) Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Shandong Quangang Pharmaceutical

        • 14.17.1 Shandong Quangang Pharmaceutical Company Profile

        • 14.17.2 Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Shanghai Sanwei Biotechnology

        • 14.18.1 Shanghai Sanwei Biotechnology Company Profile

        • 14.18.2 Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Chengdu huashen Biotechnology

        • 14.19.1 Chengdu huashen Biotechnology Company Profile

        • 14.19.2 Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Mabtech Limited

        • 14.20.1 Mabtech Limited Company Profile

        • 14.20.2 Mabtech Limited Human Interleukin-2 (IL-2) Market Performance

        • 14.20.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Human Interleukin-2 (IL-2) Industry Research Conclusions

    • 15.2 Human Interleukin-2 (IL-2) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Human Interleukin-2 (IL-2) Industry Market Size (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 50000 U (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 100000 U (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 2 Million U (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 500000 U (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 200000 U (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Production Volume, Production Value and Growth Rate of 1 Million U (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Recombinant Interferon (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Gene Therapy (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Recombinant Interleukin (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Natural Biological Products (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Monoclonal Antibody (2018-2029)

    • Figure China Human Interleukin-2 (IL-2) Sales Volume, Sales Value and Growth Rate of Poison Immune (2018-2029)

    • Figure North China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    • Figure Central China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    • Figure South China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    • Figure East China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Human Interleukin-2 (IL-2) Market Size and Growth Rate from 2018-2029

    • Figure Human Interleukin-2 (IL-2) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Human Interleukin-2 (IL-2) Market Share by Type in 2018

    • Figure China Human Interleukin-2 (IL-2) Market Share by Type in 2023

    • Figure China Human Interleukin-2 (IL-2) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 50000 U (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 100000 U (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 2 Million U (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 500000 U (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 200000 U (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Volume and Growth Rate of 1 Million U (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Market Share by Application in 2018

    • Figure China Human Interleukin-2 (IL-2) Market Share by Application in 2023

    • Figure China Human Interleukin-2 (IL-2) Total Market Size and Growth Rate from Consumption End

    • Figure China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Recombinant Interferon (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Gene Therapy (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Recombinant Interleukin (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Natural Biological Products (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Monoclonal Antibody (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Market Size and Growth Rate of Poison Immune (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Production Volume by Region (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Production Volume Share by Region (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Volume Share by Region (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Production Value by Region (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Production Value Share by Region (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Production Value Share by Region (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Sales Volume by Region (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Sales Volume Share by Region (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Sales Volume Share by Region (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Sales Value by Region (2018-2023)

    • Table China Human Interleukin-2 (IL-2) Sales Value Share by Region (2018-2023)

    • Figure China Human Interleukin-2 (IL-2) Sales Value Share by Region (2018-2023)

    • Table North China Human Interleukin-2 (IL-2) Production Volume by Type (2018-2023)

    • Table North China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Figure North China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Table North China Human Interleukin-2 (IL-2) Sales Volume by Application (2018-2023)

    • Table North China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Figure North China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Table Central China Human Interleukin-2 (IL-2) Production Volume by Type (2018-2023)

    • Table Central China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Figure Central China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Table Central China Human Interleukin-2 (IL-2) Sales Volume by Application (2018-2023)

    • Table Central China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Figure Central China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Table South China Human Interleukin-2 (IL-2) Production Volume by Type (2018-2023)

    • Table South China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Figure South China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Table South China Human Interleukin-2 (IL-2) Sales Volume by Application (2018-2023)

    • Table South China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Figure South China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Table East China Human Interleukin-2 (IL-2) Production Volume by Type (2018-2023)

    • Table East China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Figure East China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Table East China Human Interleukin-2 (IL-2) Sales Volume by Application (2018-2023)

    • Table East China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Figure East China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Human Interleukin-2 (IL-2) Production Volume by Type (2018-2023)

    • Table Northeast China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Table Northeast China Human Interleukin-2 (IL-2) Sales Volume by Application (2018-2023)

    • Table Northeast China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Human Interleukin-2 (IL-2) Production Volume by Type (2018-2023)

    • Table Southwest China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Table Southwest China Human Interleukin-2 (IL-2) Sales Volume by Application (2018-2023)

    • Table Southwest China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Human Interleukin-2 (IL-2) Production Volume by Type (2018-2023)

    • Table Northwest China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Human Interleukin-2 (IL-2) Production Volume Share by Type (2018-2023)

    • Table Northwest China Human Interleukin-2 (IL-2) Sales Volume by Application (2018-2023)

    • Table Northwest China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Human Interleukin-2 (IL-2) Sales Volume Share by Application (2018-2023)

    • Table Guangdong Xinghao Pharmaceutical Company Profile

    • Table Guangdong Xinghao Pharmaceutical Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Xiamen Tebao Biological Engineering Company Profile

    • Table Xiamen Tebao Biological Engineering Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Beijing Sihuan Biological Pharmaceutical Company Profile

    • Table Beijing Sihuan Biological Pharmaceutical Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Philogen Company Profile

    • Table Philogen Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Shenyang Sansheng Pharmaceutical Company Profile

    • Table Shenyang Sansheng Pharmaceutical Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Schering-Plough Company Profile

    • Table Schering-Plough Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table APT Therapeutics Company Profile

    • Table APT Therapeutics Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Alkermes Plc Company Profile

    • Table Alkermes Plc Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Beijing Shuanglu Pharmaceutical Company Profile

    • Table Beijing Shuanglu Pharmaceutical Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table AbbVie Inc Company Profile

    • Table AbbVie Inc Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Jiangsu Jinsili Pharmaceutical Company Profile

    • Table Jiangsu Jinsili Pharmaceutical Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Shenzhen Kexing Biological Engineering Company Profile

    • Table Shenzhen Kexing Biological Engineering Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Sinopharm Company Profile

    • Table Sinopharm Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Beijing Sanyuan Gene Pharmaceutical Company Profile

    • Table Beijing Sanyuan Gene Pharmaceutical Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Shanghai Pharma Group Company Profile

    • Table Shanghai Pharma Group Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Shandong Quangang Pharmaceutical Company Profile

    • Table Shandong Quangang Pharmaceutical Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Shanghai Sanwei Biotechnology Company Profile

    • Table Shanghai Sanwei Biotechnology Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Chengdu huashen Biotechnology Company Profile

    • Table Chengdu huashen Biotechnology Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)

    • Table Mabtech Limited Company Profile

    • Table Mabtech Limited Human Interleukin-2 (IL-2) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US